ArticleAmerican journal of respiratory and critical care medicine2020
Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 25% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis.American journal of respiratory and critical care medicine · 2026Pooled it
- Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts.International journal of environmental research and public health · 2022Pooled it
- Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Review
- Article
- Plasma kynurenine/tryptophan ratio as a sensitive blood-based diagnostic tool for tuberculosis: a diagnostic accuracy study among children living with HIV.Frontiers in microbiology · 2026Article
- Impact of tuberculosis on median survival time and years of potential life lost in patients: A scoping review.Journal of clinical tuberculosis and other mycobacterial diseases · 2025Review
- Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.Contemporary clinical trials · 2025Article
- Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Drug-resistant tuberculosis: a persistent global health concern.Nature reviews. Microbiology · 2024Review
- Multidrug-resistant tuberculosis in children: A practical update on epidemiology, diagnosis, treatment and prevention.Journal of clinical tuberculosis and other mycobacterial diseases · 2024Article
- Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis.Journal of the International AIDS Society · 2024Article
- Preventing tuberculosis with community-based care in an HIV-endemic setting: a modeling analysis.medRxiv : the preprint server for health sciences · 2023Article
- Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis.Pathogens (Basel, Switzerland) · 2023Review
- Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household.Open forum infectious diseases · 2023Article
- Preventive Therapy for Contacts of Drug-Resistant Tuberculosis.Pathogens (Basel, Switzerland) · 2022Review
- The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis.American journal of respiratory and critical care medicine · 2022Article
- Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022Article
- The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.The Lancet. Global health · 2022Article
- Prevention of Multidrug-Resistant Tuberculosis in Close Contacts. Back to the Future?American journal of respiratory and critical care medicine · 2020Article
- Tuberculosis among young contacts of patients with multidrug-resistant pulmonary tuberculosis in a reference hospital.Jornal de pediatriaArticle
Corrections and comments
- Commented on by
Authors and funding
10 authors at 5 institutions in 3 countries.
Chuan-Chin HuangDivision of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
Mercedes C BecerraDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Roger CalderonPartners in Health-Socios En Salud Sucursal, Lima, Peru.
Carmen ContrerasPartners in Health-Socios En Salud Sucursal, Lima, Peru.
Jerome GaleaSchool of Social Work, University of South Florida, Tampa, Florida.
Louis GrandjeanWellcome Centre for Clinical Tropical Medicine, Imperial College London, London, United Kingdom.
Leonid LeccaPartners in Health-Socios En Salud Sucursal, Lima, Peru.
Rosa YatacoPartners in Health-Socios En Salud Sucursal, Lima, Peru.
Zibiao ZhangDivision of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
Megan MurrayDivision of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0003-0443-1986
EsSALUD · PEBrigham and Women's Hospital · USHarvard University · USUniversidad Peruana Cayetano Heredia · PEUniversity of South Florida · US
Funding
Sequencing CoreU19AI109755 · NIAID · HARVARD MEDICAL SCHOOL · PI MURRAY, MEGAN B · 2014 to 2018
$29.1MMetabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4MReal-time surveillance to support dynamic and predictive models of MDR/XDR TBU19AI076217 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BECERRA, MERCEDES C · 2007 to 2011
$13.5MEpidemiology of multidrug-resistant tuberculosis in PeruU01AI057786 · NIAID · HARVARD MEDICAL SCHOOL · PI BECERRA, MERCEDES C · 2009 to 2010
$1.2MNIAID NIH HHS U01 AI057786NIAID NIH HHS U19 AI076217NIAID NIH HHS U19 AI109755NIAID NIH HHS U19 AI111224
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdolescentAge FactorsAnalysis of VarianceChildChild, PreschoolCohort StudiesCommunicable Disease ControlContact TracingFamily CharacteristicsFemaleHumansInfantIsoniazidMalePeruPrevalenceIsoniazidINHINH preventive therapymultidrug-resistant tuberculosistuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.